Biotechnology in Europe

Biotechnology in Europe


  • Products Id :- OHME8012
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts

Reasons To Buy

What was the size of the Europe biotechnology market by value in 2016?

What will be the size of the Europe biotechnology market in 2021?

What factors are affecting the strength of competition in the Europe biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Europe's biotechnology market?

Key Highlights

The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The European biotechnology market is expected to generate total revenues of $65.7bn in 2016, representing a compound annual growth rate (CAGR) of 5.7% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $41.8bn, equivalent to 63.6% of the market's overall value.

Europe is now only the third highest spender on R&D in the world, dropping below Asia. Although growth is forecast to continue at a strong rate, the gap in spending suggests the regions biotech industry is in need of some impetus to prevent it slipping back.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

AstraZeneca PLC

Boehringer Ingelheim GmbH

Merck & Co., Inc.

F. Hoffmann-La Roche Ltd

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

Figure 1: Europe biotechnology industry value: $ billion, 2012-16(e)

Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2016(e)

Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2016(e)

Figure 4: Europe biotechnology industry value forecast: $ billion, 2016-21

Figure 5: Forces driving competition in the biotechnology industry in Europe, 2016

Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2016

Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2016

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2016

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2016

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2016

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Boehringer Ingelheim GmbH: revenues & profitability

Figure 14: Boehringer Ingelheim GmbH: assets & liabilities

Figure 15: Merck & Co., Inc.: revenues & profitability

Figure 16: Merck & Co., Inc.: assets & liabilities

Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability

Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities

Table 1: Europe biotechnology industry value: $ billion, 2012-16(e)

Table 2: Europe biotechnology industry category segmentation: $ billion, 2016(e)

Table 3: Europe biotechnology industry geography segmentation: $ billion, 2016(e)

Table 4: Europe biotechnology industry value forecast: $ billion, 2016-21

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials ($)

Table 7: AstraZeneca PLC: key financial ratios

Table 8: Boehringer Ingelheim GmbH: key facts

Table 9: Boehringer Ingelheim GmbH: key financials ($)

Table 10: Boehringer Ingelheim GmbH: key financials (EUR)

Table 11: Boehringer Ingelheim GmbH: key financial ratios

Table 12: Merck & Co., Inc.: key facts

Table 13: Merck & Co., Inc.: key financials ($)

Table 14: Merck & Co., Inc.: key financial ratios

Table 15: F. Hoffmann-La Roche Ltd: key facts

Table 16: F. Hoffmann-La Roche Ltd: key financials ($)

Table 17: F. Hoffmann-La Roche Ltd: key financials (CHF)

Table 18: F. Hoffmann-La Roche Ltd: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AstraZeneca PLC Boehringer Ingelheim GmbH Merck & Co., Inc. F. Hoffmann-La Roche Ltd

Biotechnology, MarketLine, Europe

select a license

Single User License
USD 350 INR 22666
Site License
USD 700 INR 45332
Corporate User License
USD 1050 INR 67998

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com